Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemocomplettan P for microvascular bleeding during elective complex cardiac surgery
NL-OMON34087Phase 2Active, not recruiting
- Sponsor
- Isala
- Start
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Acquired fibrinogenopenia and perioperative bleeding comparing Haemocomplettan P with Placebo (2 arms). Primary endpoint: Perioperative blood loss. Started Mar 2011; status: active, not recruiting.
02
Drugs
Fibrinogen human
03
Conditions
Acquired fibrinogenopeniaperioperative bleeding
Beyond the preview
Go deeper on NL-OMON34087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34087.